# Adversarial review log — glymphatic-clearance

Authoring model: **Sol 6.1**. Adversarial reviewer: **Claude Opus 5.5 (Anthropic)**. Date: **2026-10-14**.
Canonical copy: `hsef_v53_final_nine_2026-10-12/glymphatic-clearance/glymphatic-clearance.review.md`.
Propagated byte-identical to `hsef_v53_remaining_priority_11_15_2026-10-11/glymphatic-clearance/glymphatic-clearance.review.md`.

## Summary

| Item | Before | After |
|---|---|---|
| HSEF level | Γ — Mechanistically plausible, partial system support | Γ (unchanged) |
| Confidence | Moderate | Moderate (unchanged) |
| Causal role | reinforcing / stabilizing factor | unchanged |
| Momentum / Stability / Divergence | Mechanistic only / Stable / Contested | unchanged (Divergence rationale given its required artifact) |
| Validator | not previously emitted | PASS — 0 fail, 0 warn, 31 pass (`validator.txt`) |

Findings by severity: **Critical 0, Major 0, Minor 2, Editorial 0** (2 corrections applied).
PMIDs checked: **60/60 references verified, 0 failed**, plus 5 linked notices (4 errata, 1 preprint predecessor) verified.
Load-bearing claims spot-checked: **10, all accurately attributed**, including the influx-versus-net-clearance distinction this literature turns on.

## Findings

| ID | Severity | Location | Correction |
|---|---|---|---|
| D1 | Minor | M/S/D; scorecard `extended_scoring_MSD.divergence` | Divergence "Contested" given the checkable artifact the framework requires: the rationale now names the split between the originating laboratories' framing and the pressure-controlled, diffusion and small-dye literature. Value unchanged. |
| D2 | Minor | Evidence cards, 5 sites | "ErratumIn:"/"UpdateOf:" → "Erratum in: PMID …"/"Update of: PMID …". |

## Rejected findings (checked, no change)

1. Γ while SC1 and SC2 sit at Ε — all three aggregation rules return Γ because SC3's scope is the registered claim's scope; the transport subclaims are reported separately as the rule requires.
2. Ε for SC1/SC2 — Ζ fails on shared tracer, preparation and constitutive-knockout assumptions; Δ would understate real endogenous perturbations. The rubric-fit adaptation is documented rather than silent.
3. Momentum "Mechanistic only" — artifact names three specific 2025-2026 programmes and what they do not do.
4. Stability "Stable" — no named pending result verified; stated as a bounded search finding.
5. Causal role at derivation step 5 — primary driver and downstream consequence both tested and rejected.
6. The Hauglund zolpidem reading — narrowing the abstract's "glymphatic flow" to the measured tracer influx is supported by `full_text_partial` access and is the opposite of overclaiming.
7. The 39-versus-38 participant discrepancy in PMID 41593094 — correctly reported as a feature of the source alongside the unadjusted multiplicity.
8. Citation years differing by one year; PubMed titles dropping Greek letters. No collective-author rendering defect in this reference list.
9. **"Best-supported rival"** — checked for the renderer defect that prints `models_evaluated[0]`: here that entry is the rank-1 non-nominal model (`is_nominal: false`) while the nominal sits lower in the tournament, so the prose is correct.
10. **Confidence band Moderate** — verified against the framework's confidence text rather than against the reviewer's access depth. Moderate is correct: the literature contains outright opposing results across tracer-delivery and pressure conditions, so the High criterion of well-established reproducibility is not met. The band is correct even though the score card's `confidence_rationale` boilerplate also mentions incomplete access.
11. **No false-approval boilerplate and no false provenance clause.** No earlier adversarial approval is asserted, and the REVIEWER NOTES provenance statements match what this case actually did, including its Consensus use.


## Files changed

- `glymphatic-clearance.review.md` — banner, `## ADVERSARIAL REVIEW AND APPROVAL`, D1, D2.
- `glymphatic-clearance.scorecard.json` — D1 divergence justification.
- `validator.txt` — new; PASS.
- `sol61-original/` — pre-review copies of the review, scorecard and validation report.

No package-level file was edited.

**Approval:** Following adversarial review and the corrections listed above, the revised document is approved.
— Claude Opus 5.5 (Anthropic), 2026-10-14.